In this free webinar, gain valuable insights into the future of data quality assessment in respiratory drug development and learn how to leverage these advancements to drive success in respiratory clinical trials. The featured speakers will discuss the limitations of traditional adherence to the American Thoracic Society (ATS)/European Respiratory Society (ERS)-enforced spirometry standards. They will expore how improved data quality can accelerate drug development, reduce costs and enable better development decisions for personalized medicine.
TORONTO, March 27, 2024 /PRNewswire-PRWeb/ -- Join this insightful webinar in which the expert speakers will explore the evolution of data quality assessments in respiratory drug development. Historically, adherence to enforced spirometry standards from the American Thoracic Society (ATS)/European Respiratory Society (ERS) guidelines has been the acceptable measure of high-quality data. However, despite refinements made in 2019 to address limitations in the historical standards, inconsistencies and aberrant treatment effects remain a persistent challenge, raising concerns over data accuracy.
Clario, a leader in clinical research and technology, has been initiating a more focused approach to ensure respiratory data accuracy within clinical trials. By introducing data plausibility as an additional quality step, data anomalies can be identified early on, thus mitigating risks and accelerating drug development timelines.
In this webinar, the speakers will explore the following topics:
- Limitations of traditional adherence to ATS/ERS enforced spirometry standards
- Role of data plausibility in enhancing data accuracy and reliability
- Impact of data plausibility on identifying inconsistencies and aberrant treatment effects
- Potential of embedding data plausibility within AI functionality to drive high-quality data
- How improved data quality can accelerate drug development, reduce costs and enable better development decisions for personalized medicine
Register for this webinar today to gain valuable insights into the future of data quality assessment in respiratory drug development and learn how these advancements can be leveraged to drive success in respiratory clinical trials.
Join experts from Clario, Kevin McCarthy, RPFT, Director, Scientific Affairs; and Philip Lake, Ph.D., Senior Director, Respiratory Solutions, for the live webinar on Wednesday, April 17, 2024, at 11 a.m. EDT (4 p.m. BST/UK).
For more information, or to register for this event, visit Going Beyond ATS/ERS 2019 Guidelines for Your Respiratory Clinical Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://www.xtalks.com
SOURCE Xtalks
Share this article